Strong Dose-Response on Immunoglobulin Makers During a Phase II Allergen Immunotherapy Study With Subcutaneously Administered Tyrosine Adsorbed Modified Grass Allergen + MPL
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.932
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Elsevier BV